Literature DB >> 429506

Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism.

E M Brown, A E Broadus, M F Brennan, D G Gardner, S J Marx, A M Spiegel, R W Downs, M Attie, G D Aurbach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429506     DOI: 10.1210/jcem-48-4-604

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  9 in total

1.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

2.  [Parathyroidectomy and autotransplantation in renal hyperparathyroidism. II. Functional in vitro studies for tissue selection].

Authors:  B Niederle; H Hörandner; R Roka; W Wolosczuk; T Waldhör
Journal:  Langenbecks Arch Chir       Date:  1988

3.  Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice.

Authors:  Y Imanishi; Y Hosokawa; K Yoshimoto; E Schipani; S Mallya; A Papanikolaou; O Kifor; T Tokura; M Sablosky; F Ledgard; G Gronowicz; T C Wang; E V Schmidt; C Hall; E M Brown; R Bronson; A Arnold
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.

Authors:  María Martín-Salvago; José L Villar-Rodríguez; Alfonso Palma-Alvarez; Antonio Beato-Moreno; Hugo Galera-Davidson
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

5.  Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children.

Authors:  J A Ramirez; W G Goodman; C Menezes; G V Segre; I B Salusky
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism.

Authors:  W Graf; J Rastad; G Akerström; L Wide; S Ljunghall
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 7.  Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials.

Authors:  William G Goodman
Journal:  Pediatr Nephrol       Date:  2003-10-28       Impact factor: 3.714

8.  Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.

Authors:  Priyanka Singh; Sanjay Kumar Bhadada; Divya Dahiya; Ashutosh Kumar Arya; Uma Nahar Saikia; Naresh Sachdeva; Jyotdeep Kaur; Maria Luisa Brandi; Sudhaker Dhanwada Rao
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

Review 9.  The Calcium-Sensing Receptor and the Parathyroid: Past, Present, Future.

Authors:  Arthur D Conigrave
Journal:  Front Physiol       Date:  2016-12-15       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.